Interestingly, Wang et al. discovered that intraperitoneal injection with aluminium adjuvant alone can activate CD8+ T cells, thereby killing tumour cells that were subcutaneously inoculated in mouse and significantly reducing the tumour volume in a non-specific way [21]. The gene discussed is CD8A; the disease is neoplasm.